4
Changes in Ownership
Upstream Bio, Inc. Filed Acc 0000950170-24-114802
10% owner acquired 894,733 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-10-15 | Conversion | +894,733 | 894,733 | D | ||
| Derivatives | |||||||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2024-10-15 | Conversion · Series B redeemable convertible preferred stock | −852,940 | 0 | D | ||
Loading xslF345X05/ownership.xml…